Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug-induced Parkinsonism”

29 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 29 results

Not applicableStudy completedNCT02761707
What this trial is testing

Biomarkers in Neural Disorders

Who this might be right for
Parkinson's DiseaseAlzheimer's DiseaseProgressive Supranuclear Palsy+6 more
University of Pennsylvania 54
Testing effectiveness (Phase 2)UnknownNCT03944447
What this trial is testing

Outcomes Mandate National Integration With Cannabis as Medicine

Who this might be right for
Chronic PainChronic Pain SyndromeChronic Pain Due to Injury+30 more
OMNI Medical Services, LLC 200,000
Not applicableStudy completedNCT01429207
What this trial is testing

Capturing Parkinson's Disease Medication Side Effects During Daily Activities

Who this might be right for
Parkinson's DiseaseDyskinesia
Great Lakes NeuroTechnologies Inc. 15
Not applicableActive Not RecruitingNCT02252380
What this trial is testing

ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement Disorders

Who this might be right for
Movement DisordersEssential TremorHolmes Tremor+6 more
InSightec 10
Testing effectiveness (Phase 2)UnknownNCT04147949
What this trial is testing

AV-101 (L-4-chlorokynurenine) in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesia

Who this might be right for
Parkinson DiseaseDyskinesia, Medication-InducedL-Dopa Causing Adverse Effects in Therapeutic Use
VistaGen Therapeutics, Inc. 20
Testing effectiveness (Phase 2)Ended earlyNCT01789047
What this trial is testing

Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's DiseaseDrug Induced Dyskinesia
Rush University Medical Center 42
Not applicableLooking for participantsNCT06570824
What this trial is testing

RTMS as an Intervention for Levodopa-induced Dyskinesia

Who this might be right for
Dyskinesia, Drug-InducedParkinson Disease
Danish Research Centre for Magnetic Resonance 68
Testing effectiveness (Phase 2)Study completedNCT02657681
What this trial is testing

Prevention of Levodopa-induced Dyskinesias by Transcranial Static Magnetic Field Stimulation (tSMS)

Who this might be right for
Dyskinesia, Medication-InducedParkinson's Disease
Fundación de investigación HM 50
Large-scale testing (Phase 3)Ended earlyNCT04857359
What this trial is testing

Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy

Who this might be right for
Parkinson DiseaseDyskinesia, Drug-InducedDyskinesias
Addex Pharma S.A. 25
Not applicableStudy completedNCT02598973
What this trial is testing

Effect of Exercise in Parkinsonism

Who this might be right for
Parkinson's DiseaseDrug-induced Parkinsonism
VA Office of Research and Development 9
Testing effectiveness (Phase 2)Study completedNCT05297201
What this trial is testing

Efficacy, Safety and Pharmacokinetic Study of CPL500036 in Patients with Levodopa Induced Dyskinesia

Who this might be right for
Parkinson DiseaseDyskinesia, Medication-Induced
Celon Pharma SA 105
Testing effectiveness (Phase 2)Study completedNCT05148884
What this trial is testing

Study to Assess the Safety, Tolerability and Preliminary Efficacy of NLX-112 Versus Placebo in L-dopa-induced Dyskinesia

Who this might be right for
Medication-Induced Dyskinesia
Neurolixis SAS 27
Not applicableStudy completedNCT04064294
What this trial is testing

Preventing Levodopa Induced Dyskinesia in Parkinson's Disease With HMG-CoA Reductase Inhibitors

Who this might be right for
Parkinson DiseaseDyskinesia, Drug-Induced
VA Office of Research and Development 93
Large-scale testing (Phase 3)Ended earlyNCT05116813
What this trial is testing

Open-label Safety Study of Dipraglurant (ADX48621) in Patients With Parkinson's Disease Receiving Levodopa-based Therapy

Who this might be right for
Parkinson DiseaseDyskinesia, Drug-InducedDyskinesias
Addex Pharma S.A. 17
Early research (Phase 1)Enrolling By InvitationNCT06344026
What this trial is testing

Phase 1/2a Study of ANPD001 in Parkinson Disease

Who this might be right for
Parkinson Disease
Aspen Neuroscience 9
Testing effectiveness (Phase 2)Study completedNCT01092065
What this trial is testing

Efficacy and Safety of AFQ056 When Combined With Increased Doses of L-dopa in Parkinson's Disease Patients With Moderate-severe L-dopa Induced Dyskinesia

Who this might be right for
Parkinson's Disease
Novartis 23
Not applicableLooking for participantsNCT05317390
What this trial is testing

Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia

Who this might be right for
DystoniaDrug Induced DystoniaParkinson Disease+8 more
Massachusetts Eye and Ear Infirmary 1,000
Large-scale testing (Phase 3)WithdrawnNCT03987750
What this trial is testing

Safinamide for Levodopa-induced Dyskinesia (PD-LID)

Who this might be right for
Dyskinesia, Drug-InducedParkinson Disease
Zambon SpA
Testing effectiveness (Phase 2)Study completedNCT01173731
What this trial is testing

Open Label, Safety, Tolerability and Efficacy of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

Who this might be right for
Parkinson DiseaseDyskinesia, Drug-InducedLevodopa
Novartis Pharmaceuticals 66
Testing effectiveness (Phase 2)Ended earlyNCT00686699
What this trial is testing

Study of Preladenant for the Treatment of Antipsychotic Induced Movement Disorders in Participants With Schizophrenia (Study P04628)

Who this might be right for
Akathisia, Drug-InducedDyskinesia, Drug-InducedParkinsonian Disorders
Merck Sharp & Dohme LLC 11
Load More Results